Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 20Polycystic Ovary Syndrome 10Prostatic Neoplasms 7Breast Neoplasms 6Neoplasms 5Colorectal Neoplasms 4Insulin Resistance 3Lung Neoplasms 2Fatigue 2Esophageal Neoplasms 2Cardiotoxicity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Dysautonomias 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Inflammation 1Hodgkin Disease 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Diabetes Mellitus, Type 1 1Chemotherapy-Related Cognitive Impairment 1Cardiovascular Diseases 1

Interventions

Paclitaxel 328Carboplatin 323Bevacizumab 171Gemcitabine 106liposomal doxorubicin 104pembrolizumab 100Topotecan 94Cyclophosphamide 94olaparib 92Cisplatin 92niraparib 69Docetaxel 57Taxes 52Doxorubicin 51Drug Therapy 45fludarabine 39Filgrastim 39Nivolumab 37Magnetic Resonance Spectroscopy 34Surveys and Questionnaires 33Specimen Handling 33Etoposide 32Hyperthermic Intraperitoneal Chemotherapy 31Blood Specimen Collection 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Cytoreduction Surgical Procedures 25Albumin-Bound Paclitaxel 25durvalumab 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × High-Intensity Interval Training × Clear all
NCT05029154 2025-06-12

Exercise Preconditioning in Ovarian Cancer

University of Virginia

Phase NA Terminated
8 enrolled
Gynecologic

Ovarian Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡